PTPI PTPI

Petros Pharmaceuticals Stock Price

0.7397
-0.0271 (-3.53%)
Upgrade to Real-Time
Regular Market
0.7397
Volume 181,011
Bid Price 0.7302
Ask Price 0.7401
News -
Day High 0.78

Low
0.6458

52 Week Range

High
5.20

Day Low 0.73
Company Name Stock Ticker Symbol Market Type
Petros Pharmaceuticals Inc PTPI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0271 -3.53% 0.7397 13:05:19
Open Price Low Price High Price Close Price Prev Close
0.7614 0.73 0.78 0.7668
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
344 181,011 $ 0.7527293 $ 136,252 - 0.6458 - 5.20
Last Trade Time Type Quantity Stock Price Currency
13:05:10 100 $ 0.7397 USD

Period:

Draw Mode:

Petros Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.30M 20.68M 12.79M $ 7.81M $ -6.47M -0.83 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 0.10%

more financials information »

Petros Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTPI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.78890.820.730.7889726280,990-0.0492-6.24%
1 Month0.9412.880.670.81457432,371,958-0.2013-21.39%
3 Months0.68822.880.670.8237128979,1750.05157.48%
6 Months1.562.880.64581.151,288,123-0.8203-52.58%
1 Year2.485.200.64582.975,326,556-1.74-70.17%
3 Years1.805.95990.64582.983,175,148-1.06-58.91%
5 Years1.805.95990.64582.983,175,148-1.06-58.91%

Petros Pharmaceuticals Description

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease.
Your Recent History
NASDAQ
PTPI
Petros Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220818 17:22:20